United-Guardian FY2025 operating income drops to $2.2 million; net sales fall 13% to $10.5 million

Reuters
Mar 27
United-Guardian FY2025 operating income drops to $2.2 million; net sales fall 13% to $10.5 million
  • United-Guardian published a press release reporting FY 2025 financial results.
  • FY 2025 net sales fell 13% to USD 10.55 million.
  • FY 2025 net income declined to USD 2.11 million, or USD 0.46 per share.
  • Management said FY 2025 results were primarily impacted by lower cosmetic ingredients sales due to excess inventory at distributor Ashland Specialty Ingredients and weaker demand in China amid local competition and tariffs.
  • FY 2025 pharmaceutical sales rose 15% and medical lubricants sales increased 4%, with Donna Vigilante citing higher Renacidin awareness efforts and approval from two major pharmacy benefit managers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United-Guardian Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603270900PRIMZONEFULLFEED9679404) on March 27, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10